Last reviewed · How we verify
Basal cell carcinoma of skin
Approved treatments
- Erismodegib · Washington University School of Medicine
- Erivedge · Roche
Vismodegib inhibits the Hedgehog pathway by binding to and blocking Smoothened, a key protein in the pathway.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Basal cell carcinoma of skin patent landscape — cliff calendar, originator estates, attackable patents
- Basal cell carcinoma of skin treatment landscape brief
- Basal cell carcinoma of skin treatment updates RSS
Frequently asked questions about Basal cell carcinoma of skin
What drugs treat Basal cell carcinoma of skin?
Tracked treatments include Erismodegib, Erivedge.
What is the treatment for Basal cell carcinoma of skin?
Standard treatment for Basal cell carcinoma of skin includes Erismodegib, Erivedge. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Basal cell carcinoma of skin patent cliff · Basal cell carcinoma of skin CI report
- Treatment: Erismodegib · Washington University School of Medicine
- Treatment: Erivedge · Roche
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing